DermiSense is developing a flexible and biocompatible microneedle technology to extract dermal interstitial fluid (the liquid just below the surface of our skin). This painless microscopic technology creates a powerful platform with diverse applications, and is uniquely optimized for long-term extraction and sensing.
| Website | https://dermisensehealth.com/ |
| Employees | 2 (1 on RocketReach) |
| Founded | 2018 |
| Address | 2500 Regency Pkwy, Cary, North Carolina 27518, US |
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Liquid Biopsy, Microneedle Patches, Skin Diagnostics, Skin Health Technology, Transdermal Drug Delivery, Point Of Care Diagnostics |
| Competitors | Dermalogica, Obagi, Murad, SkinCeuticals, Neutrogena, Cerave, La Roche-Posay USA, Aveeno, Eucerin, Proactiv Skin Solution +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular DermiSense Inc employee's phone or email?
DermiSense Inc Questions
John Strang is the CEO of DermiSense Inc.
1 people are employed at DermiSense Inc.
DermiSense Inc is based in Cary, North Carolina.
The NAICS codes for DermiSense Inc are [325, 32].
The SIC codes for DermiSense Inc are [28, 283].
Top DermiSense Inc Employees
-
John Strang
Chief Executive Officer at DermiSense Inc
Chapel Hill, NC, US35+
